KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $30.3 million.

  • Bionano Genomics' Non-Current Assets fell 2506.07% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.3 million, marking a year-over-year decrease of 4751.73%. This contributed to the annual value of $37.2 million for FY2024, which is 4994.88% down from last year.
  • As of Q3 2025, Bionano Genomics' Non-Current Assets stood at $30.3 million, which was down 2506.07% from $33.3 million recorded in Q2 2025.
  • Bionano Genomics' 5-year Non-Current Assets high stood at $150.2 million for Q4 2022, and its period low was $14.6 million during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $72.4 million (2024), whereas its average is $72.9 million.
  • As far as peak fluctuations go, Bionano Genomics' Non-Current Assets skyrocketed by 66631.29% in 2021, and later plummeted by 5376.8% in 2024.
  • Over the past 5 years, Bionano Genomics' Non-Current Assets (Quarter) stood at $104.7 million in 2021, then soared by 43.48% to $150.2 million in 2022, then plummeted by 50.54% to $74.3 million in 2023, then plummeted by 49.95% to $37.2 million in 2024, then decreased by 18.61% to $30.3 million in 2025.
  • Its Non-Current Assets stands at $30.3 million for Q3 2025, versus $33.3 million for Q2 2025 and $33.5 million for Q1 2025.